Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

364 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies.
Zarrabi A, Perrin D, Kavoosi M, Sommer M, Sezen S, Mehrbod P, Bhushan B, Machaj F, Rosik J, Kawalec P, Afifi S, Bolandi SM, Koleini P, Taheri M, Madrakian T, Łos MJ, Lindsey B, Cakir N, Zarepour A, Hushmandi K, Fallah A, Koc B, Khosravi A, Ahmadi M, Logue S, Orive G, Pecic S, Gordon JW, Ghavami S. Zarrabi A, et al. Among authors: orive g. Cancers (Basel). 2023 Nov 2;15(21):5269. doi: 10.3390/cancers15215269. Cancers (Basel). 2023. PMID: 37958442 Free PMC article. Review.
Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression.
Ashrafizadeh M, Mirzaei S, Gholami MH, Hashemi F, Zabolian A, Raei M, Hushmandi K, Zarrabi A, Voelcker NH, Aref AR, Hamblin MR, Varma RS, Samarghandian S, Arostegi IJ, Alzola M, Kumar AP, Thakur VK, Nabavi N, Makvandi P, Tay FR, Orive G. Ashrafizadeh M, et al. Among authors: orive g. Carbohydr Polym. 2021 Nov 15;272:118491. doi: 10.1016/j.carbpol.2021.118491. Epub 2021 Jul 27. Carbohydr Polym. 2021. PMID: 34420747 Free article. Review.
Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance.
Ashrafizadeh M, Saebfar H, Gholami MH, Hushmandi K, Zabolian A, Bikarannejad P, Hashemi M, Daneshi S, Mirzaei S, Sharifi E, Kumar AP, Khan H, Heydari Sheikh Hossein H, Vosough M, Rabiee N, Kumar Thakur V, Makvandi P, Mishra YK, Tay FR, Wang Y, Zarrabi A, Orive G, Mostafavi E. Ashrafizadeh M, et al. Among authors: orive g. Expert Opin Drug Deliv. 2022 Apr;19(4):355-382. doi: 10.1080/17425247.2022.2041598. Epub 2022 Apr 3. Expert Opin Drug Deliv. 2022. PMID: 35152815
Chitosan-based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy.
Ashrafizadeh M, Hushmandi K, Mirzaei S, Bokaie S, Bigham A, Makvandi P, Rabiee N, Thakur VK, Kumar AP, Sharifi E, Varma RS, Aref AR, Wojnilowicz M, Zarrabi A, Karimi-Maleh H, Voelcker NH, Mostafavi E, Orive G. Ashrafizadeh M, et al. Among authors: orive g. Bioeng Transl Med. 2022 Sep 13;8(1):e10325. doi: 10.1002/btm2.10325. eCollection 2023 Jan. Bioeng Transl Med. 2022. PMID: 36684100 Free PMC article. Review.
Nanotherapeutic approaches for brain cancer management.
Saenz del Burgo L, Hernández RM, Orive G, Pedraz JL. Saenz del Burgo L, et al. Among authors: orive g. Nanomedicine. 2014 Jul;10(5):905-19. doi: 10.1016/j.nano.2013.10.001. Epub 2013 Oct 14. Nanomedicine. 2014. PMID: 24135564 Review.
The future of psychiatry should be One Health.
Lertxundi U, Domingo-Echaburu S, Brodin T, Medrano J, Orive G. Lertxundi U, et al. Among authors: orive g. Rev Environ Health. 2022 Mar 7;38(2):399-400. doi: 10.1515/reveh-2022-0019. Print 2023 Jun 27. Rev Environ Health. 2022. PMID: 35254745 No abstract available.
Emerging immunomodulatory strategies for cell therapeutics.
Chua CYX, Jiang AY, Eufrásio-da-Silva T, Dolatshahi-Pirouz A, Langer R, Orive G, Grattoni A. Chua CYX, et al. Among authors: orive g. Trends Biotechnol. 2023 Mar;41(3):358-373. doi: 10.1016/j.tibtech.2022.11.008. Epub 2022 Dec 20. Trends Biotechnol. 2023. PMID: 36549959 Free article. Review.
364 results